Automated Nucleic Acid Extraction Devices Market 2025

Automated Nucleic Acid Extraction Devices Market Size

The global automated nucleic acid extraction devices market reached a value of nearly $5,934.86 million in 2024, having grown at a compound annual growth rate (CAGR) of 12.08% since 2019. The market is expected to grow from $5,934.86 million in 2024 to $9,947.65 million in 2029 at a rate of 10.88%. The market is then expected to grow at a CAGR of 10.57% from 2029 and reach $16,438.98 million in 2034. Growth in the historic period resulted from the rising R&D spending in life sciences, increased prevalence of infectious diseases, increasing cancer screening and biomarker discovery and rising demand for personalized medicine. Factors that negatively affected growth in the historic period were high equipment cost and mixing efficiency. Going forward, growing investments in biopharmaceutical manufacturing, favorable government initiatives, increasing demand for molecular diagnostics and expanding genomic research activities will drive the growth. Factor that could hinder the growth of the automated nucleic acid extraction devices market in the future include increasing regulatory scrutiny, high competition and impact of trade war and tariff.

Automated Nucleic Acid Extraction Devices Market Drivers

The key drivers of the Automated Nucleic Acid Extraction Devices market include: Increasing Demand For Molecular Diagnostics Increasing demand for molecular diagnostics is expected to propel the growth of the automated nucleic acid extraction devices market going forward. The rising demand for molecular diagnostics drives the growth of automated nucleic acid extraction devices by increasing the need for rapid, accurate, and high-throughput sample preparation. Automated systems improve workflow efficiency, reduce human error, and enable consistent extraction of high-quality nucleic acids essential for reliable diagnostic results. As molecular tests become more common in detecting infectious diseases, cancer, and genetic conditions, labs require scalable and standardized extraction solutions, fueling market expansion. This demand also encourages innovation in automation technology to meet diverse clinical and research needs. Therefore, the increasing demand for molecular diagnostics will drive the growth of the automated nucleic acid extraction devices market.

Automated Nucleic Acid Extraction Devices Market Restraints

The key restraints on the Automated Nucleic Acid Extraction Devices market include: Increasing Regulatory Scrutiny Increasing regulatory scrutiny is expected to hamper the growth of the automated nucleic acid extraction devices market. Increasing regulatory scrutiny hampers the automated nucleic acid extraction devices industry by prolonging product approval timelines and increasing compliance costs. Stricter regulations require manufacturers to conduct extensive validation and documentation to meet quality and safety standards, which can delay market entry. This added complexity may discourage smaller companies from innovation and slow the launch of new or improved devices. Consequently, regulatory hurdles can limit market growth and slow technology adoption in clinical settings. Therefore, the increasing regulatory scrutiny may hinder the growth of the automated nucleic acid extraction devices market.

Automated Nucleic Acid Extraction Devices Market Trends

Major trends shaping the Automated Nucleic Acid Extraction Devices market include: Focus on Advancing Fully Automated, Maxi-Scale DNA Purification Technologies Companies operating in the automated nucleic acid extraction devices market are focusing on developing fully automated, maxi-scale purification systems that eliminate manual steps such as setup, centrifugation and pipetting. These innovations use self-contained cartridges with preloaded reagents to simplify workflows, reduce contamination risks and accelerate the production of high-purity plasmid DNA for advanced therapeutics. For instance, in June 2024, Thermo Fisher Scientific, a US-based biotechnology company specializing in scientific instrumentation, reagents, and laboratory services, introduced the Thermo Scientific KingFisher PlasmidPro Maxi Processor (PlasmidPro), the only fully automated maxi-scale plasmid DNA purification system aimed at accelerating therapeutic discovery and development. This advanced system enables fully automated processing from culture to purified plasmid DNA without any manual steps such as setup, centrifugation or pipetting, using a self-contained cartridge preloaded with all required reagents. Designed to handle 100–150 mL of overnight culture and deliver up to 1.5 mg of high-purity plasmid DNA in about 75 minutes, PlasmidPro simplifies workflows, minimizes contamination risk and supports the rapid progress of cell and gene therapies, monoclonal antibody development, mRNA-based treatments and vaccines amid increasing global clinical trial activity. Innovative Cartridge-Based Platform Accelerates Genomic Analysis Companies operating in the automated nucleic acid extraction devices market are focusing on developing technologically advanced solutions, such as automated platform for extracting high molecular weight (HMW) DNA, to improve yield, purity, and efficiency in downstream applications such as long-read sequencing, genomic analysis, and clinical diagnostics. An automated platform for extracting high molecular weight (HMW) DNA is a specialized system designed to isolate long, intact DNA fragments with minimal shearing, enabling high-quality input for advanced genomic applications like long-read sequencing. For instance, in May 2023, One BioMed Pte. Ltd., a Singapore-based biotechnology company, launched the X8 HMW DNA Cartridge Kits, the world’s first fully automated, out-of-the-box platform for extracting high molecular weight (HMW) DNA across diverse sample types. Powered by the OneTouch Instrument and proprietary Xceler8 technology, the system enables rapid, high-quality DNA extraction without mechanical disruption or ethanol-based steps—ideal for long-read sequencing and genome assembly applications.

Opportunities And Recommendations In The Automated Nucleic Acid Extraction Devices Market

Opportunities – The top opportunities in the automated nucleic acid extraction devices markets segmented by type will arise in the instruments segment, which will gain $1,507.45 million of global annual sales by 2029. The top opportunities in the automated nucleic acid extraction devices markets segmented by product will arise in the fully automated segment, which will gain $3,146.04 million of global annual sales by 2029. The top opportunities in the automated nucleic acid extraction devices markets segmented by end user will arise in the pharmaceutical and biotechnology companies segment, which will gain $1,226.61 million of global annual sales by 2029. The automated nucleic acid extraction devices market size will gain the most in the USA at $1,064.92 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the automated nucleic acid extraction devices market companies to focus on fully automated maxi-scale systems to strengthen competitive position, focus on fully automated maxi-scale systems to strengthen competitive position, focus on fully automated maxi-scale systems to strengthen competitive position, focus on high molecular weight dna extraction for advanced genomic applications, focus on kits segment to maximize long-term growth potential, focus on kits segment to maximize long-term growth potential, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, continue to use b2b promotions, focus on diagnostic centers to maximize growth potential.